| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 07/17/2003 | WO2003057209A1 Method for the preparation of matairesinol |
| 07/17/2003 | WO2003057173A2 Broad spectrum inhibitors |
| 07/17/2003 | WO2003057169A2 4-dedimethylamino tetracycline compounds |
| 07/17/2003 | WO2003057132A2 Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile |
| 07/17/2003 | US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics |
| 07/17/2003 | US20030134895 Method for the preparation of citalopram |
| 07/17/2003 | US20030134852 Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 07/17/2003 | US20030131422 Primary intermediates for oxidative coloration of hair |
| 07/17/2003 | CA2472580A1 Broad spectrum inhibitors |
| 07/17/2003 | CA2471760A1 Preventives/remedies for urinary disturbance |
| 07/16/2003 | EP1326824A1 Pharmaceutical compounds |
| 07/16/2003 | EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | EP0831967B1 Shaped hydrogenation catalyst and processes for their preparation and use |
| 07/16/2003 | CN1430603A Novel bicyclic compounds |
| 07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |
| 07/16/2003 | CN1430599A Phenylglycine derivatives |
| 07/16/2003 | CN1430596A New gamma selective retinoids |
| 07/16/2003 | CN1114596C Biphenyl derivatives |
| 07/16/2003 | CN1114594C D4 receptor selectivity piperazine derivatives |
| 07/16/2003 | CN1114488C Improved catalyst for preparing 1,4-butanediol by hydrogenation of maleic acid |
| 07/15/2003 | US6593495 Anhydride stabilization |
| 07/15/2003 | US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes |
| 07/15/2003 | US6593481 Hydrogenation of 3,4-tetrahydrofurandiol to tetrahydrofuran |
| 07/15/2003 | US6593478 Preparing carnitine |
| 07/15/2003 | US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents |
| 07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
| 07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6592911 (−)-Olivil as antioxidant which is obtained from a new natural source namely Stereospermum personatum |
| 07/15/2003 | US6592884 Method of using alpha-keto enamine derivatives as ingredients and products incorporating same |
| 07/15/2003 | US6592631 Useful as developer compounds in oxidation dye compositions for keratin fibers. |
| 07/15/2003 | CA2218766C Bicyclic-aromatic compounds |
| 07/10/2003 | WO2003055871A1 DECAHYDRONAPHTHO[2,3-c]FURAN DERIVATIVES |
| 07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| 07/10/2003 | WO2003055848A2 Urea derivatives as vr1- antagonists |
| 07/10/2003 | WO2003055847A1 Carboxylic acid derivative |
| 07/10/2003 | WO2003055484A1 Urea derivatives |
| 07/10/2003 | WO2001098248A3 Hiv integrase inhibitors |
| 07/10/2003 | US20030130529 Method for obtaining 2-bromo-5-(2-bromo-2-nitrovinyl)-furan |
| 07/10/2003 | US20030130528 Prepared from a source of fructose in a one-pot, two-step reaction, in a single solvent system process, using a vanadium catalyst. |
| 07/10/2003 | US20030130527 Citalopram; halogenating 5-cyanophthalide to form 2-(halomethyl)-4-cyanobenzoyl halide; reaction with p-fluorophenyl- borane or metal halide; reacting with 3-(dimethylamino)propylmetal halide |
| 07/10/2003 | US20030130523 Delivers more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood; substituted phenylacetanilides containing carboxyl group(s) |
| 07/10/2003 | US20030130520 Producing substituted 2-nitro-guanidine derivatives. |
| 07/10/2003 | US20030130514 Preparation of alpha-diimines |
| 07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
| 07/10/2003 | US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents |
| 07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
| 07/10/2003 | US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect |
| 07/10/2003 | US20030129758 Colorless and soluble in organic products, use for detecting petroleum fuels or solvents |
| 07/10/2003 | US20030129712 By reacting heterocyclic ketones with a cyanide donor in the presence of a hydroxynitrile lyase |
| 07/10/2003 | CA2482392A1 Carboxylic acid derivative |
| 07/10/2003 | CA2471236A1 Urea derivatives |
| 07/10/2003 | CA2469967A1 Urea derivatives as vr1- antagonists |
| 07/09/2003 | EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 07/09/2003 | EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | EP1233939A4 Process for preparing optically active alpha-hydroxy acids and derivatives thereof |
| 07/09/2003 | EP1232151B1 Method for production of benzofuranone oximes |
| 07/09/2003 | EP1173430B1 Enantiomers of mercapto lactones and processes for their synthesis |
| 07/09/2003 | EP1073620B1 Method for producing 1,4-butanediol |
| 07/09/2003 | EP1066277B1 Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
| 07/09/2003 | EP1066251B1 Method for the production of 1,3-disubstituted 2-nitroguanidines |
| 07/09/2003 | EP0901483B1 Benzofurans and benzopyrans as chronobiological agents |
| 07/09/2003 | CN1429220A Crystalline base of citalopram |
| 07/09/2003 | CN1429219A Method for preparation of citalopram |
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1429198A Novel phenyl-proparylether derivatives |
| 07/09/2003 | CN1429196A Process for preparation of aniline compounds |
| 07/09/2003 | CN1428339A Preparation method of ascorbic acid aliphatic ester |
| 07/09/2003 | CN1428324A Process for preparing hydroaromatic polybasic carboxylic acid and process for preparing hydroaromatic polybasic carboxylic anhydride |
| 07/09/2003 | CN1113877C Effective synthetic method for furau sulfonic acid amide compound for synthesizing new IL-1 inhibitor |
| 07/09/2003 | CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/08/2003 | US6590118 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes) |
| 07/08/2003 | US6590109 Suspending plant material or extract in presence of oxidation reagent, extracting terpene trilactones using acceptable extraction agent, separating organic layer from aqueous layer to isolate terpene trilactones in organic layer |
| 07/08/2003 | US6590108 Methods for the preparation of dianhydrides |
| 07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 07/08/2003 | US6589976 Particularly effective wood preservation is achieved by impregnation processes on a large industrial scale, for example vacuum, a double vacuum or pressure processes. |
| 07/08/2003 | US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 07/08/2003 | US6589914 Dihalopropene compounds, insecticidal/acaridcidal agents containing same, and intermediates for their production |
| 07/08/2003 | US6588374 (tetrahydro-3-furanyl) methylamine derivative dissolved in a solvent comprising water and phenyl methanol or a combination of ethanol and ethyl lactate; dinotefuran; fleas |
| 07/03/2003 | WO2003053971A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053948A1 Isochroman compounds for treatment of cns disorders |
| 07/03/2003 | WO2003053927A1 Piperazine derivative |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | WO2003053368A2 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | WO2003017942A3 Ascorbic acid derivatives with amino acids |
| 07/03/2003 | WO2003011822A3 Solid phase syntheis of salts of organic acid |
| 07/03/2003 | WO2002016340A8 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 07/03/2003 | US20030125590 For effecting reactions and/or separations using organic molecule, moiety or group having a domain or a portion thereof rich in carbon-fluorine bonds |
| 07/03/2003 | US20030125558 5-bromosalicylaldehyde is reacted in a one-pot reaction firstly with haloaceticalkyl or benzylester and then with formamide to give 5-L-benzofuran-2-carboxamide, then transition metal-catalyzed ammination with piperazines |
| 07/03/2003 | US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/03/2003 | US20030125556 Having an aryl group bonded to a carbon atom in an azomethine moiety and containing amido and amine groups; useful for silver halide photographic photosensitive materials and for printing material in ink jet or thermal printing |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125329 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125328 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125309 Cyclic ether vitamin D3 compounds, 1alpha(OH) 3-epi- vitamin D3 compounds and uses thereof |
| 07/03/2003 | US20030125306 N-methyl-6-phenyl-3,5-hexadienoylhydroxamic acid as an example; gene expression inhibition; antitumor and -carcinogenic agents; blood disorders (hemoglobinopathies); genetic disorders/metabolic disorders (cystic fibrosis) |
| 07/03/2003 | CA2471089A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | CA2470931A1 Chalcone derivatives and their use to treat diseases |